Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04148547
Other study ID # uammadrid4
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date June 30, 2019

Study information

Verified date October 2019
Source Universidad Autonoma de Madrid
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main aim of this study is to assess the short-term effects of active-tDCS (a-tDCS) on the M1 regarding sensorimotor variables such as discriminative sensation, pressure pain threshold and electromyographic activity compared with a sham-tDCS (s-tDCS) in healthy individuals. The main objective was to determine whether there were clinically relevant changes generated by tDCS and if they were superior to a sham intervention.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date June 30, 2019
Est. primary completion date June 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- asymptomatic participants

- men and women aged 18 to 65 years

Exclusion Criteria:

- insomnia

- nausea

- headache

- pregnancy

- use of painkillers in the last 24 hours

- presence of metal inside the head

- pacemaker

- wound on the area of electrodes' application

- drug consumption; (j) recent application of tDCS

- psychiatric disease impeding understanding of the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Sooma transcranial direct current stimulation device
This group received brain training through transcranial direct current for 20 minutes.
Placebo Sooma transcranial direct current stimulation device
This group received sham brain training through transcranial direct current for 20 minutes. The current is active for 15 seconds and then switches off until the intervention is finished.

Locations

Country Name City State
Spain CSEU La Salle Madrid

Sponsors (2)

Lead Sponsor Collaborator
Universidad Autonoma de Madrid Centro Universitario La Salle

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pressure pain threshold through an algometer Pressure pain threshold has been defined as the minimal amount of pressure at which a sense of pressure first changes to pain or discomfort Change in pressure pain threshold immediately at the end of the intervention
Primary Tactile acuity threshold Tactile acuity threshold is an important variable to know the somatosensory state and Von Frey monofilaments and Aesthesiometer were used Change in tactile acuity threshold immediately at the end of the intervention
Primary Muscle recruitment through electromyographic activity The activity of surface electromyography (sEMG) during an isometric maximal voluntary contraction was measured in the biceps brachii and rectus femoris. Change in electromyographic activity immediately at the end of the intervention
See also
  Status Clinical Trial Phase
Completed NCT05544201 - Transcranial Alternating Current Stimulation (TACS) for Sleep Disturbances in Neurocognitive Disorders Due to Alzheimer's Disease N/A
Completed NCT05254080 - taVNS Cold Pressor N/A
Completed NCT03720665 - Cortical Excitability Changes on the Sensorimotor Cortex Induced by Caffeine Consumption: A TMS Study N/A
Completed NCT02697110 - Family Inclusive Early Brain Stimulation N/A
Completed NCT04011670 - Neuroplastic Alterations of the Motor Cortex by Caffeine N/A
Completed NCT04046055 - Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease N/A
Completed NCT02498574 - Performance Enhancement and Non-Invasive Brain Stimulation N/A